Clicky

Roche Holding Ltd ADR(RHO6) News

Date Title
Dec 5 While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Dec 5 Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Dec 5 The Fed Is Watching Jobs Data. Why It Should Be Listening to Spotify.
Dec 5 Genentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Dec 5 Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Dec 4 Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker
Dec 4 Roche Buys Carmot Therapeutics to Compete in Booming Market for Weight-Loss Drugs
Dec 4 Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
Dec 4 Roche: fat fighter drugs buy must precede trial wins
Dec 4 Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.
Dec 4 Roche bets on obesity market with Carmot deal
Dec 4 Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies
Dec 4 Roche joins race for obesity drugs with $2.7 billion Carmot deal
Dec 4 Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments
Dec 4 Roche to Buy Obesity Drug Maker Carmot for $3.1 Billion
Dec 4 Roche joins obesity drug chase with $2.7B deal for startup Carmot
Dec 4 UPDATE 4-Roche joins race for obesity drugs with $2.7 bln Carmot deal
Dec 4 Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Nov 28 Roivant’s Matt Gline on raising capital and biotech’s outlook for 2024
Nov 27 Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection